This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Whats it like recruiting in the world of high-security clearances and 3-letter government agencies? In this replay of one of our most downloaded episodes, the founder of Cyber Security Recruiters shares how he took a chance on an industry before it exploded, and the intricacies of recruiting for the government.
Her corporate governance experience includes current service on the boards of West Pharmaceutical Services, AMSURG, and First Solar and as vice chair of the board of trustees at Santa Clara University in Santa Clara, CA.
ASRT's position, according to ASRT Vice President of Governance and Public Policy Jason Bradley, is that "states should have strong licensure laws to ensure highly qualified and educated professionals are performing medical imaging and radiation therapy procedures. For CT and MRI procedures where injected contrast media is ordered, ".
In this new position, he brings more than 20 years of operational and leadership expertise in the pharmaceutical and life sciences industry to the Company. Previous to Catalent, he was Managing Director, North America, with SEQENS CDMO, a global leader in pharmaceutical solutions (CDMO, Generic APIs).
In that role, he partnered with providers, healthcare system executives, and government leaders to improve healthcare quality, access, and affordability. More recently, Cooper served as CEO of Shields Health Solutions, a premier specialty pharmacy builder and accelerator for health systems, until it was acquired by Walgreens in December 2022.
What’s it like recruiting in the world of high-security clearances and 3-letter government agencies? In this episode, the founder of Cyber Security Recruiters shares how he took a chance on an industry before it exploded, and the intricacies of recruiting for the government.
TeleDaaS specializes in delivering clinical-grade, precision-based dosimetry analysis and treatment plans to clinical research organizations (CROs) and pharmaceutical manufacturers. TeleDaaS’s technology and processes are tightly governed by robust quality methodologies and the platforms are information security compliant.
Cardiovascular care has seen remarkable advancements over the decades, from innovative surgical techniques to cutting-edge pharmaceuticals. AI governance in cardiology must also address potential biases in data and ensure that all populations are fairly represented. Yet, challenges remain. Artifice means deceit.
Indian government has taken definitive steps towards inclusive healthcare committing to make India healthier and a model to be emulated by the rest of world. Government schemes like ‘Ayushman Bharat,’ allocates funds towards improving healthcare infrastructure in Tier 2 and 3 cities along with rural areas.
GE HealthCare is sharing the findings to encourage discussion, partnerships, and actions with stakeholders across the industry: patients, the broad spectrum of healthcare professionals, healthcare leaders, elected government officials, technology industry leaders, and the public.
The study was funded by a government organization as opposed to a pharmaceutical company. Demographics were well balanced in the two groups. Patients were actively screened for DVT (all received lower extremity ultrasound on or around day 7). Limitations: Patients were not consecutively recruited which may introduce bias.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content